The safety crisis concerning infant food products has intensified. The recall by Nestlé of selected batches of modified milk under the brands SMA, BEBA, NAN, and Alfamino now covers at least 37 countries across four continents, including major markets such as Brazil and China. The reason for the recall is potential contamination with cereulide, a toxin that can cause gastrointestinal symptoms such as nausea and vomiting.
Scope of Product Recall
The Austrian Ministry of Health revealed that the recall involves over 800 products from more than 10 manufacturing facilities of the company. This is the largest such action in the producer’s history, known for brands like KitKat and Nescafé. The Netherlands, as the production hub, has been identified as the source of the contaminated ingredient, although the batch recalled in Australia originates from Swiss-based facilities.
Market Reactions in Brazil and China
Brazil’s Ministry of Health announced its decision to withdraw the products as a precautionary measure, confirming earlier reports of the issue. Meanwhile, Nestlé’s Chinese divisions confirmed the removal of imported batches from Europe from circulation. Both markets have issued consumer warnings.
Capital Market Disruptions and Remedial Plans
The news of the recall significantly impacted Nestlé’s stock prices, which fell about 4.5 percent over the past week. Pressure on the company’s management is increasing, especially in light of recent leadership changes and the new CEO Philipp Navratil’s ambitions to revive growth through product portfolio reorganization.
Mitigation Actions
Nestlé has taken steps to restore stability in the supply chain. The company has analyzed the entire batch of arachidonic acid oil and related oil blends used in the production of the affected infant dietary products. In response, the company is actively increasing production capacity and engaging alternative arachidonic acid oil suppliers to ensure the continuity of product supplies in global markets.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Global Food Security Crisis: Nestlé withdraws products in Brazil, China, and other countries
The safety crisis concerning infant food products has intensified. The recall by Nestlé of selected batches of modified milk under the brands SMA, BEBA, NAN, and Alfamino now covers at least 37 countries across four continents, including major markets such as Brazil and China. The reason for the recall is potential contamination with cereulide, a toxin that can cause gastrointestinal symptoms such as nausea and vomiting.
Scope of Product Recall
The Austrian Ministry of Health revealed that the recall involves over 800 products from more than 10 manufacturing facilities of the company. This is the largest such action in the producer’s history, known for brands like KitKat and Nescafé. The Netherlands, as the production hub, has been identified as the source of the contaminated ingredient, although the batch recalled in Australia originates from Swiss-based facilities.
Market Reactions in Brazil and China
Brazil’s Ministry of Health announced its decision to withdraw the products as a precautionary measure, confirming earlier reports of the issue. Meanwhile, Nestlé’s Chinese divisions confirmed the removal of imported batches from Europe from circulation. Both markets have issued consumer warnings.
Capital Market Disruptions and Remedial Plans
The news of the recall significantly impacted Nestlé’s stock prices, which fell about 4.5 percent over the past week. Pressure on the company’s management is increasing, especially in light of recent leadership changes and the new CEO Philipp Navratil’s ambitions to revive growth through product portfolio reorganization.
Mitigation Actions
Nestlé has taken steps to restore stability in the supply chain. The company has analyzed the entire batch of arachidonic acid oil and related oil blends used in the production of the affected infant dietary products. In response, the company is actively increasing production capacity and engaging alternative arachidonic acid oil suppliers to ensure the continuity of product supplies in global markets.